Today's Date
A Cooperative Clinical Study of Abatacept in Multiple Sclerosis
(
ACCLAIM
)
ITN Protocol #:
ITN035AI
Branded Name:
ACCLAIM
ClinicalTrials.Gov ID:
NCT01116427Treatment Protocol #:
Abatacept
Therapeutic Area:
Autoimmune Disease
Current Status:
Complete
Summary:
A Phase II, Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicenter Study to Evaluate the Safety and Efficacy of Abatacept in Adults with Relapsing-remitting Multiple Sclerosis
Clinical Operations Associate Director
Clinical Operations Manager
ITN Biologist
ITN Clinical Trial Physician
NIAID Project Manager
Rho Data Manager
Rho Scientist
Study Personnel:
